DTIL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Precision BioSciences (DTIL) Earnings Date & Reports

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DTIL is expected to report earnings to fall 97.00% to -6 cents per share on March 12

Precision BioSciences DTIL Stock Earnings Reports

Q4'23

Est.

$-0.07

Q4'24

Missed

by $2.18

Q1'24

Beat

by $1.81

Q3'23

Beat

by $0.12

Q2'23

Beat

by $0.15

The last earnings report on March 26 showed earnings per share of -222 cents, missing the estimate of -3 cents. With 85.37K shares outstanding, the current market capitalization sits at 58.03M.

View a ticker or compare two or three

Compare

DTIL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For DTIL
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of technology to produce custom, genome-editing enzymes for human health and biological research

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

302 East Pettigrew Street

Phone

+1 919 314-5512

Employees

109

Web

https://www.precisionbiosciences.com